Skip to main content
Fig. 2 | Stem Cell Research & Therapy

Fig. 2

From: A small molecule modulating monounsaturated fatty acids and Wnt signaling confers maintenance to induced pluripotent stem cells against endodermal differentiation

Fig. 2

Cell growth determination using BrdU incorporation assay. The induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs) were treated with SCD1 inhibitor (SCDinhib) alone at Days 0, 1, or 2 (0, 1, and 2) of differentiation or in combination with oleic acid (OA) on Day 0. Undifferentiated cells (Undiff) and cells treated with DMSO (< 0.05%, Mock) were served as background controls. The cells were harvested on Day 4

Back to article page